Best Agrolife Ltd

Best Agrolife Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Best Agrolife Ltd

₹ 279 1.99%
04 Apr 3:31 p.m.
bestagrolife.com BSE: 539660 NSE: BESTAGRO
About

Best Agrolife (formerly known as Sahyog Multibase Limited) [1] is a leading agrochemicals manufacturer in India and is among the top 15 agrochemicals companies in the country. It is one of the fastest growing manufacturers of Technicals, Formulations, Intermediates and Public Health products. Best Agrochem Private Limited was amalgamated with the Co. in April 2018.

It offers more than 70 Formulations in the form of Insecticides, Herbicides, Fungicides and Plant Growth Regulators, which are developed from active ingredients manufactured in-house. As part of its P2P set-up, Best Agrolife caters to several blue-chip corporates and leading MNCs from India and abroad. [2]

Key Points

Business Overview
The company is the 13th Largest Indian Agrochemical Company, with a portfolio of 490+ formulations and 115+ technical manufacturing licenses. It offers a wide range of herbicides, insecticides, fungicides, and plant growth regulators including Ronfen, Citigen, Tricolor, Azaro, Cubax Power, etc. [1] [2] [3]

Website BSE NSE - BE
  • Market Cap ₹ 660 Cr.
  • Current Price ₹ 279
  • High / Low ₹ 732 / 244
  • Stock P/E 34.2
  • Book Value ₹ 320
  • Dividend Yield 1.08 %
  • ROCE 16.5 %
  • ROE 18.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.88 times its book value
  • Company has a good return on equity (ROE) track record: 3 Years ROE 32.3%

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Part of BSE Allcap BSE SmallCap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
232 309 464 700 328 254 612 811 314 135 519 747 274
200 247 398 518 270 247 482 667 296 202 465 600 280
Operating Profit 32 62 66 183 58 7 130 144 19 -67 55 147 -6
OPM % 14% 20% 14% 26% 18% 3% 21% 18% 6% -50% 11% 20% -2%
-0 1 0 1 1 1 4 -3 1 1 3 1 -0
Interest 5 7 7 9 10 13 12 15 19 15 16 16 16
Depreciation 3 7 6 6 6 7 7 8 6 11 10 10 11
Profit before tax 23 49 53 168 43 -12 115 118 -6 -92 32 121 -33
Tax % 34% 23% 25% 23% 29% -28% 21% 19% 3% -22% 33% 22% -26%
15 38 40 130 31 -8 90 95 -7 -72 21 95 -24
EPS in Rs 6.55 16.14 16.97 54.90 12.95 -3.56 38.27 40.12 -2.80 -30.66 9.00 40.03 -10.22
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
127 151 905 1,211 1,746 1,873 1,675
126 154 854 1,045 1,432 1,648 1,547
Operating Profit 1 -2 51 166 314 226 129
OPM % 0% -1% 6% 14% 18% 12% 8%
1 4 7 2 3 3 5
Interest 1 2 5 15 39 62 64
Depreciation 0 0 3 12 24 33 42
Profit before tax 0 0 51 141 253 134 28
Tax % 575% 100% 27% 26% 24% 21%
-0 0 37 105 192 106 19
EPS in Rs -0.65 0.03 16.83 44.31 81.27 44.94 8.15
Dividend Payout % -0% 798% 12% 5% 4% 7%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 27%
TTM: -16%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 42%
TTM: -89%
Stock Price CAGR
10 Years: %
5 Years: 6%
3 Years: -37%
1 Year: -59%
Return on Equity
10 Years: %
5 Years: %
3 Years: 32%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 8 8 22 24 24 24 24
Reserves 46 48 108 306 504 623 732
0 19 33 270 568 637 578
63 35 209 384 380 729 1,069
Total Liabilities 117 110 372 984 1,475 2,013 2,403
0 0 19 180 203 362 355
CWIP -0 -0 4 5 14 15 13
Investments 32 3 -0 -0 -0 -0 -0
85 107 349 800 1,258 1,636 2,035
Total Assets 117 110 372 984 1,475 2,013 2,403

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-14 -41 13 -60 -180 36
-34 31 8 -15 -19 -63
48 10 -11 67 248 -1
Net Cash Flow 0 -0 10 -8 49 -29

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 85 87 53 77 73 91
Inventory Days 67 199 391 864
Days Payable 72 124 167 521
Cash Conversion Cycle 85 87 48 152 297 434
Working Capital Days 61 175 43 117 157 162
ROCE % 0% 41% 34% 16%

Shareholding Pattern

Numbers in percentages

4 Recently
Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
45.42% 47.30% 47.30% 48.20% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10%
11.31% 10.82% 11.27% 12.05% 11.48% 10.84% 9.86% 8.86% 8.77% 8.73% 8.03% 5.11%
0.20% 0.20% 2.57% 2.57% 2.58% 2.55% 2.63% 2.53% 2.53% 2.53% 2.67% 2.74%
43.08% 41.68% 38.86% 37.16% 35.84% 36.50% 37.42% 38.50% 38.60% 38.62% 39.18% 42.06%
No. of Shareholders 8,2258,76011,36021,20623,03927,20031,94037,57139,86141,57040,57337,666

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls